Skip to content
A6518Assembly2023-2024 SessionSame asS966

Expand Drug Plan Eligibility

Official title

“Provides for program eligibility for plans comparable to Medicare part D”

Sponsor Yudelka TapiaAD-86+15 co-sponsorsAffects Health
Status
In Assembly Committee
Aging
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Aging

What's happening

This bill expands eligibility for the elderly pharmaceutical insurance coverage program to include drug plans comparable to Medicare Part D.

Why it matters

  1. Increases flexibility and choice for seniors. by allowing them to enroll in public or private drug plans that provide coverage at least as comprehensive as Medicare Part D, rather than being limited strictly to Medicare Part D itself.

  2. Potentially reduces out-of-pocket costs. for eligible elderly individuals, since the state program will cover the monthly premium portion for these alternative plans, just as it currently does for Medicare Part D, as long as the plans meet federal standards for coverage.

  3. Could improve access to medications and plan features. that better meet individual needs, since some private or public plans may offer broader formularies, lower co-pays, or other benefits not available through standard Medicare Part D plans.

  4. Requires oversight and verification. that any alternative drug plan is genuinely as generous as Medicare Part D, ensuring that seniors remain protected from inadequate coverage while expanding their coverage options.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Expand Drug Plan Eligibility

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to aging
  2. Referred to aging

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S966Senate

Expand Drug Plan Eligibility

In Assembly Committee · Aging · Sponsor Gustavo Rivera

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6518

2023-2024 Regular Sessions

IN ASSEMBLY

April 12, 2023

Introduced by M. of A. TAPIA, DE LOS SANTOS -- read once and referred to the Committee on Aging

AN ACT to amend the elder law, in relation to program eligibility for plans comparable to Medicare part D

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraphs (f) and (h) of subdivision 3 and subdivision 4 of section 242 of the elder law, paragraph (f) of subdivision 3 as amended by section 1 of part T of chapter 56 of the laws of 2012, paragraph (h) of subdivision 3 as amended by section 3-f of part A of chapter 59 of the laws of 2011, and subdivision 4 as added by section 12-a of part T of chapter 56 of the laws of 2012, are amended to read as follows:

(f) As a condition of eligibility for benefits under this title, a program participant is required to be enrolled in Medicare part D, or any other public or private drug plan which has successfully demonstrated to CMS that the coverage is as generous as, or more generous than the defined standard coverage under the Medicare part D prescription drug benefit, and to maintain such enrollment. For unmarried participants with individual annual income less than or equal to twenty-three thousand dollars and married participants with joint annual income less than or equal to twenty-nine thousand dollars, the elderly pharmaceutical insurance coverage program shall pay for the portion of the part D or comparable plan monthly premium that is the responsibility of the participant. Such payment shall be limited to the low-income benchmark premium amount established by the federal centers for medicare and medicaid services and any other amount which such agency establishes under its de minimus premium policy.

(h) The elderly pharmaceutical insurance coverage program is authorized to represent program participants under this title with respect to their Medicare part D or comparable coverage.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03604-01-3

4. As a condition of eligibility for benefits under this title, participants must be enrolled in [medicare] Medicare part D, or any other public or private drug plan which has successfully demonstrated to CMS that the coverage is as generous as, or more generous than the defined standard coverage under the Medicare part D prescription drug benefit, and maintain such enrollment. For persons who meet the eligibility requirements to participate in the elderly pharmaceutical insurance coverage program, the program will pay for a drug covered by the person's [medicare] Medicare part D plan or comparable plan or a drug in a [medicare] Medicare part D excluded drug class, as defined in subdivision eight of section two hundred forty-one of this title, provided that such drug is a covered drug, as defined in subdivision one of section two hundred forty-one of this title, and that the participant complies with the point of sale co-payment requirements set forth in sections two hundred forty-seven and two hundred forty-eight of this title. No payment shall be made for [medicare] Medicare part D or comparable plan deductibles.

§ 2. This act shall take effect on the first of April next succeeding the date on which it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.